Skip to content

Effect of L-92 for ECRS

Effect of L-92 for ECRS - ECRS and L-92

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035967
Enrollment
30
Registered
2019-02-21
Start date
2018-02-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic rhinosinusitis

Interventions

Addministration of L-92 once a day.

Sponsors

Faculty of Medicine, Kagawa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ECRS patients with prior-surgery30

Exclusion criteria

Exclusion criteria: Under 20 years old oral PSL user

Design outcomes

Primary

MeasureTime frame
Endoscopic paranasal score

Countries

Japan

Contacts

Public ContactKosuke Akiyama

Faculty of Medicine, Kagawa University Department of Otolaryngology

kakaka@med.kagawa-u.ac.jp087-891-2214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026